| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AYRO, Inc. | Executive Chairman, Director | Common Stock | 189K | $154K | $0.82 | Dec 2, 2024 | Direct |
| MyMD Pharmaceuticals, Inc. | Director | Employee Stock Option (Right to Buy) | 200K | Jun 7, 2023 | Direct | ||
| PharmaCyte Biotech, Inc. | Interim CEO, Interim President, Director | Stock Option (Right to Buy) | 170K | Nov 20, 2023 | Direct | ||
| AYRO, Inc. | Executive Chairman, Director | Cash-Settled Restricted Stock Units | 97.4K | Dec 2, 2024 | Direct | ||
| Petros Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 40K | Dec 21, 2023 | Direct | ||
| FEMASYS INC | Director | Stock Option (Right to Buy) | 17.6K | Jul 12, 2024 | Direct | ||
| Petros Pharmaceuticals, Inc. | Director | Common Stock | 11.2K | Apr 26, 2023 | Direct | ||
| Synaptogenix, Inc. | Director | Stock Option (Right to Buy) | 800 | Apr 8, 2024 | Direct | ||
| Petros Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | Apr 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AYRO | AYRO, Inc. | Dec 2, 2024 | 3 | $0 | 4 | Dec 2, 2024 | Executive Chairman, Director |
| FEMY | FEMASYS INC | Jul 12, 2024 | 1 | $0 | 4 | Jul 15, 2024 | Director |
| SNPX | Synaptogenix, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Director |
| FEMY | FEMASYS INC | Nov 21, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Director |
| FEMY | FEMASYS INC | Nov 21, 2023 | 0 | $0 | 3 | Nov 22, 2023 | Director |
| PMCB | PharmaCyte Biotech, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Interim CEO, Interim President, Director |
| AYRO | AYRO, Inc. | Aug 1, 2023 | 1 | -$10.4K | 4 | Aug 3, 2023 | Director |
| MYMD | MyMD Pharmaceuticals, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| AYRO | AYRO, Inc. | May 3, 2023 | 1 | -$5.81K | 4 | May 5, 2023 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Apr 26, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Apr 10, 2023 | 1 | $0 | 4 | Apr 12, 2023 | Director |
| SNPX | Synaptogenix, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
| AYRO | AYRO, Inc. | Jan 30, 2023 | 2 | -$5.11K | 4 | Feb 3, 2023 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 25, 2023 | Director |
| SNPX | Synaptogenix, Inc. | Dec 16, 2022 | 1 | -$22.3K | 4 | Dec 20, 2022 | Director |
| SNPX | Synaptogenix, Inc. | Nov 15, 2022 | 1 | $0 | 4/A | Dec 1, 2022 | Director |
| PMCB | PharmaCyte Biotech, Inc. | Aug 15, 2022 | 0 | $0 | 3 | Aug 23, 2022 | Director |
| AYRO | AYRO, Inc. | May 11, 2022 | 2 | -$14.8K | 4 | Nov 3, 2022 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Apr 7, 2022 | 1 | $0 | 4 | Apr 11, 2022 | Director |
| SNPX | Synaptogenix, Inc. | Apr 5, 2022 | 1 | $0 | 4/A | Jun 23, 2022 | Director |
| AYRO | AYRO, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Director |
| PTPI | Petros Pharmaceuticals, Inc. | Dec 22, 2021 | 1 | $0 | 4 | Jan 7, 2022 | Director |
| MYMD | MyMD Pharmaceuticals, Inc. | Nov 24, 2021 | 3 | $103K | 4 | Nov 29, 2021 | Director |
| MYMD | MyMD Pharmaceuticals, Inc. | Oct 14, 2021 | 1 | $0 | 4 | Oct 15, 2021 | Director |
| SNPX | Synaptogenix, Inc. | Jul 13, 2021 | 1 | $0 | 4/A | Dec 1, 2022 | Director |
| SNPX | Synaptogenix, Inc. | Jun 14, 2021 | 1 | $83K | 4 | Jun 16, 2021 | Director |
| SNPX | Synaptogenix, Inc. | Jun 4, 2021 | 0 | $0 | 3 | Jun 14, 2021 | Director |
| AYRO | AYRO, Inc. | Jun 4, 2021 | 1 | -$202K | 4 | Jun 8, 2021 | Director |